Suchergebnisse

1. Policy process / Alan Lyles -- 2. Federal legislative process / Valerie Heitshusen -- 3. Role of federal regulations and how they are developed / Curtis W. Copeland -- 4. Access, quality, and cost / Julie A. Schmittdiel and Marsha Raebel -- 5. Why is medication use less than appropriate? / Duane M. Kirking, David Nau, and Jill Augustine -- 6. Medication adherence and health policy / Meghan M. Kelly and Jon C. Schommer -- 7. Good governance and corruption in the pharmaceutical system / Jillian Clare Kohler -- 8. U.S. Food and Drug Administration / Gregory Dolin -- 9. Risk minimization : a new regulatory challenge directive / Louis A. Morris and Eva Lydick -- 10. Drug shortages / Anna Gu, Dhamil Patel, and Rajesh Nayak -- 11. Drug reimportation into the United States / Albert I. Wertheimer and Qian Ding -- 12. Competition between brand-name and generic drugs / Jianfei J. Guo and Christina M.L. Kelton -- 13. Structure and dynamics of the pharmaceutical industry / Earlene Lipowski -- 14. Health policy and economic issues in biotechnology and personalized medicine / Louis P. Garrison, Jr. -- 15. Pharmaceutical promotion in the United States / Alan Lyles -- 16. Health technology assessment / Laura T. Pizzi and Tony Amos -- 17. Pharmacoeconomics as a response to market failure : an international perspective / Ruth Lopert -- 18. Market for pharmaceuticals / David H. Kreling -- 19. Managed care pharmacy and pharmacy benefit management / Perry Cohen and Mary Claire Wohletz -- 20. Drug insurance design and management / Earle Buddy Lingle and William N. Yates -- 21. Electronic information technology : role in supporting drug use and policy / Gordon Schiff, Tewodros Eguale, and Bill G. Felkey -- 22. Assessing medicare part D after 10 years / Jack Hoadley -- 23. Medicaid / Brian K. Bruen and Linda Elam -- 24. Medication therapy management services / Brian J. Isetts -- 25. The Affordable Care Act : potential impacts on pharmaceutical markets / Steven H. Sheingold and Pierre L. Yong -- 26. Role of government as regulator, payer, and provider of care / W. Mike Heath and John Spain -- 27. Department of veterans affairs pharmacy programs / Vaiyapuri Subramaniam and Michael A. Valentino -- 28. Public health service / Robert E. Pittman.

"Pharmaceutical Public Policy provides the understanding and framework required for effective organization, financing, and delivery of pharmaceutical products and services. It supplies an overview of the policy process as well as the roles of legislation and regulation in pharmaceutical policy. The book identifies the goals, objectives, and key policy issues of concern to stakeholders involved in the development of products, use of pharmaceuticals in healthcare, and administration of insurance programs by both the private and government sectors. Policy issues examined include the appropriateness of prescribing and patient adherence. Addressing questions of access, quality, and cost, the book considers the operation of the Affordable Care Act and Medicare Part D. It details the responsibilities of Federal providers of pharmaceutical care and private and public payers such as managed care organizations, pharmacy benefit managers, Medicare, and Medicaid. The book covers the policies and practices involved in promoting pharmaceutical products. It also considers pharmacoeconomics as a response to market failure. Finally, the book describes the market, the role of the manufacturer, drug shortages, and the responsibilities of the FDA."--